WOMAN Trials Wrapped: Highlights from 2024
2024 has been an extremely busy year for the WOMAN Trials team. From publishing and presenting the WOMAN-2 Trial results, to planning the WOMAN-3 Trial and starting recruitment for the …
Tranexamic acid cuts life-threatening bleeding after birth, but anaemia prevention is critical, studies show
Two papers from the WOMAN Trials Collaborators, published in The Lancet today, reveal important evidence on the effects of the drug tranexamic acid (TXA) on postpartum haemorrhage (PPH) and life-threatening …
Looking ahead: What next for WHO’s roadmap to fight PPH and WOMAN Trials research to reduce maternal deaths
This article was written by the WOMAN Trials team. A year ago today, the WHO released its first roadmap to combat deaths from postpartum haemorrhage (PPH) – a condition …
Discussions on data, drafts and dissemination: The WOMAN Trials writing committee meeting
“Some of the most disadvantaged women took part in the WOMAN-2 Trial. They shared their experiences with us so that we could learn from them. “This is why we’ve been …
Tranexamic acid can reduce surgical bleeding and blood transfusions
Wider use of tranexamic acid (TXA) in surgery would improve surgical outcomes, avoid unnecessary blood transfusions and conserve blood stocks, according to an article published today in the British Medical …